CASE REPORT

Treatment of Symptomatic Vitreomacular Adhesion with Expansile Sulfur Hexafluoride (SF6) Gas

The Open Ophthalmology Journal 28 Apr 2017 CASE REPORT DOI: 10.2174/1874364101711010080

Abstract

Background:

To evaluate intravitreal injection of expansile sulfur hexafluoride (SF6) as a low cost and effective treatment for symptomatic vitreomacular adhesion (sVMA).

Methods:

Retrospective analysis of all patients with sVMA treated with pneumatic vitreolysis using SF6 gas presenting to a clinical practice from January 2005 and June 2013.

Results:

Six cases were included in the study. Five patients (83%) experienced complete resolution of the vitreomacular adhesion. One patient had a partial release of the vitreomacular adhesion. Four patients (67%) had a one line improvement in best corrected visual acuity.

Conclusion:

Due to its low cost, wide availability, and apparent efficacy, intravitreal injection of expansile SF6 should be investigated further as a possible treatment modality for sVMA.

Keywords: Intravitreal, Vitreomacular, Adhesion, Expansile, Diabetes, Sulphur hexaflouride.
Fulltext HTML PDF ePub
1800
1801
1802
1803
1804